ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,476Medicare Part D Prescriptions Filled, Including Refills

Rank: 870 out of 2888

$355K Total Retail Price of All Prescriptions

Rank: 1247 out of 2888

370 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
6% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

8% of this provider’s 370 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 7,033 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
AMLODIPINE BESYLATE 318 294 1 5
LOSARTAN POTASSIUM 314 314 2 18
SIMVASTATIN 257 244 3 2
HYDROCHLOROTHIAZIDE 221 214 4 15
LEVOTHYROXINE SODIUM 203 196 5 1
PRAVASTATIN SODIUM 166 155 6 12
LISINOPRIL 166 159 6 3
FUROSEMIDE 148 148 8 6
ATORVASTATIN CALCIUM 130 125 9 9
OMEPRAZOLE 128 124 10 7
WARFARIN SODIUM 126 126 11 22
METOPROLOL TARTRATE 110 110 12 10
POTASSIUM CHLORIDE 107 94 13 14
AZITHROMYCIN 103 92 14 38
SERTRALINE HCL 102 90 15 27
HYDROCODONE-ACETAMINOPHEN 101 63 S3 16 4
ATENOLOL 100 89 17 25
CITALOPRAM HBR 98 93 18 24
METFORMIN HCL 96 95 19 8
METOPROLOL SUCCINATE 93 87 20 11
SPIRONOLACTONE 87 82 21 70
DIGOXIN 86 86 22 55
CARVEDILOL 85 69 23 21
BENAZEPRIL HCL 84 77 24 77
FLUTICASONE PROPIONATE 80 67 25 32
DIOVAN 79 79 26 35
VERAPAMIL ER 78 77 27 104
TAMSULOSIN HCL 75 75 28 29
ALLOPURINOL 71 71 29 37
TRAMADOL HCL 69 55 30 16
MIRTAZAPINE 67 65 31 54
FAMOTIDINE 65 65 32 75
FINASTERIDE 62 62 33 102
CYCLOBENZAPRINE HCL 56 46 R 34 68
GABAPENTIN 56 51 34 13
BISOPROLOL FUMARATE 55 55 36 227
FELODIPINE ER 55 53 36 175
DOXAZOSIN MESYLATE 54 54 38 94
DONEPEZIL HCL 51 51 39 26
TRAZODONE HCL 50 50 40 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 29, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.